A study shows high efficacy in a controlled setting but limited effectiveness in practice due to patient variability. This illustrates the difference between which two concepts?

A study shows high efficacy in a controlled setting but limited effectiveness in practice due to patient variability. This illustrates the difference between which two concepts?

• A. Efficacy and Effectiveness
• B. Power and Sample Size
• C. Efficacy and Safety
• D. Randomization and Validity

Answer: (A)

Efficacy versus effectiveness is what's being illustrated. Efficacy refers to how well a treatment works under ideal, tightly controlled conditions—where participants are carefully selected, adherence is monitored, and variables are kept constant. Effectiveness, on the other hand, describes how well the treatment works in real-world practice, where patient variability (differences in adherence, comorbidities, and everyday clinical settings) can reduce the observed benefit. In the scenario, a treatment shows strong results in a controlled trial but not in routine practice because real patients vary and don’t always follow protocols, highlighting the gap between efficacy (ideal conditions) and effectiveness (real-world use). The other concepts don’t capture this distinction: statistical power and sample size relate to detecting effects, not to real-world performance; efficacy and safety juxtapose benefit with potential harms, not generalizability across patient populations; and randomization with validity concerns study design and accuracy, not the gap between controlled and real-world outcomes.

Efficacy versus effectiveness is what's being illustrated. Efficacy refers to how well a treatment works under ideal, tightly controlled conditions—where participants are carefully selected, adherence is monitored, and variables are kept constant. Effectiveness, on the other hand, describes how well the treatment works in real-world practice, where patient variability (differences in adherence, comorbidities, and everyday clinical settings) can reduce the observed benefit. In the scenario, a treatment shows strong results in a controlled trial but not in routine practice because real patients vary and don’t always follow protocols, highlighting the gap between efficacy (ideal conditions) and effectiveness (real-world use). The other concepts don’t capture this distinction: statistical power and sample size relate to detecting effects, not to real-world performance; efficacy and safety juxtapose benefit with potential harms, not generalizability across patient populations; and randomization with validity concerns study design and accuracy, not the gap between controlled and real-world outcomes.